Literature DB >> 7380195

Evidence against purinergic inhibitory nerves in the vagal pathway to the opossum lower esophageal sphincter.

S Rattan, R K Goyal.   

Abstract

Studies were performed on anesthetized opossums. Lower esophageal sphincter pressures were measured with waterfilled and continously perfused catheters anchored in the sphincter. Administration of adenosine 5'-triphosphate (ATP) and ADP in the left gastric artery usually produced an initial contraction followed by a more prolonged inhibition. Adenosine, on the other hand, produced only inhibition. The effect of ATP was not modified by phentolamine (1 mg/kg), propranolol (1 mg/kg) or atropine (30 micrograms/kg). Tetrodotoxin partially antagonized (P less than 0.05) the inhibitory effects of ATP and adenosine, but augmented the excitatory effect of ATP (P less than 0.05). 2-2'-Pyridylisatogen tosylate selectively antagonized the effects of ATP without modifying the effect of adenosine. This antagonist, however, did not modify the resting sphincter pressure or the vagal stimulated sphincter relaxation. Dipyridamole enhanced the inhibitory effect of adenosine, but did not augment vagal stimulates sphincter relaxation. There was no cross-tachyphylaxis between ATP and adenosine. Tachyphylaxis, either to ATP or adenosine, did not inhibit the vagal stimulated sphincter relaxation. These studies show that: (a) ATP and adenosine may act on different receptor sites to modify sphincter pressure; (b) only a small part of the inhibitory effect of ATP and adenosine is mediated by the inhibitory neurons; (c) neither ATP nor adenosine appears to be the inhibitory transmitter released by the noncholinergic, nonadrenergic inhibitory neurons in the vagal pathway to the lower esophageal sphincter.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380195

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  7 in total

1.  Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.

Authors:  B F King; C Dacquet; A U Ziganshin; D F Weetman; G Burnstock; P M Vanhoutte; M Spedding
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 2.  What's new in the esophagus.

Authors:  J Dent
Journal:  Dig Dis Sci       Date:  1981-02       Impact factor: 3.199

Review 3.  Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders.

Authors:  R Farré; D Sifrim
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

4.  Nitric oxide involvement in the peptide VIP-associated inhibitory junction potential in the guinea-pig ileum.

Authors:  X D He; R K Goyal
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

5.  Neither a purine nor VIP is the mediator of inhibitory nerves of opossum oesophageal smooth muscle.

Authors:  E E Daniel; A Helmy-Elkholy; L P Jager; M S Kannan
Journal:  J Physiol       Date:  1983-03       Impact factor: 5.182

6.  Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation.

Authors:  P Biancani; J H Walsh; J Behar
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Gastric motor responses elicited by vagal stimulation and purine compounds in the atropine-treated rabbit.

Authors:  K Beck; F Calamai; G Staderini; T Susini
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.